Medivir appoints commercial executive vice president

pharmafile | May 17, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Juserius, Medivir 

Research-based speciality firm Medivir has appointed Henric Juserius to be the new head of the company’s commercial activities. 

Juserius who will have overall responsibility for Medivir’s pharma marketing and sales joins the company in August, and will be part of the management team.

Juserius has a degree in business administration and most recently held the position as commercial director for the Nordic region at Actelion Pharmaceuticals. He has extensive experience in the industry and has worked in marketing and sales for more than 20 years in companies such as AstraZeneca, GSK, Pfizer, Serono and Actelion.

“I am very pleased to welcome Henric Juserius to Medivir as executive vice president, commercial. His extensive experience and broad expertise in marketing and sales of prescription drugs from both large and small pharmaceutical companies will be invaluable now that Medivir is approaching a market launch in the Nordic countries of its flagship product for hepatitis C, TMC435. 

Advertisement

“Henric will also work on the development of Medivir’s existing portfolio of prescription drugs,” says Maris Hartmanis, president and chief executive of Medivir.

Related Content

Cancer Research Technology and Medivir to develop new class of cancer drugs

Cancer Research Technology and Medivir will join forces to develop a new class of drugs …

Twitter image

Twitter ‘drama’ produces drubbing for Medivir

A NASDAQ disciplinary committee has found Medivir guilty of breaching its rules after data from …

mosquito

Medivir and Janssen in dengue fever research alliance

Medivir, the speciality pharma company focused on infectious diseases, it to collaborate with Janssen on …

The Gateway to Local Adoption Series

Latest content